Oticon More vs Signia Pure Charge&Go MaX

The Oticon More is a premium prescription behind-the-ear hearing aid that earns an A grade with a SoundScore of 4.6/5 in our lab testing, placing it in the top 23% of the 39 prescription hearing aids we've evaluated. Currently available at $4,598, this 2021 release has earned our Expert's Choice Award in both 2023 and 2024. In our testing, the Oticon More demonstrates strong speech clarity performance. Speech in quiet scores 4.0/5, which is 0.65 points above the category average—a meaningful advantage for everyday conversation. Speech in noise measures 2.7/5, which is 0.60 points above the category average, though the absolute score reflects the inherent challenge all hearing aids face in noisy environments. Own-voice comfort is solid at 3.1/5, sitting 0.40 points above average. The device does show one notable weakness: feedback handling scores 3.5/5, which is 1.22 points below the category average of 4.72/5. While this is still a solid score in absolute terms, competing devices in this price range generally perform better in this area. Music streaming is solid at 3.0/5, slightly above the category average. The Oticon More offers flexibility with both rechargeable and disposable battery options, plus streaming compatibility with both iPhone and Android devices including hands-free calling. For those considering alternatives, newer models like the Oticon Intent and Oticon Real score higher in our testing at similar price points. The Oticon More remains a capable choice for listeners who prioritize speech clarity and want a well-established platform with proven performance.

The Signia Pure Charge&Go MaX is a behind-the-ear prescription hearing aid released in 2026 that earns an A grade with a SoundScore of 4.3/5 in HearAdvisor's lab testing. This strong overall performance reflects solid results across key listening scenarios, with particular strengths in own-voice comfort and speech understanding in noisy environments. In our testing, the Pure Charge&Go MaX demonstrated notable advantages over the prescription hearing aid category average. Own-voice comfort scored 1.00 points above the category average at 3.7/5, suggesting effective management of occlusion-related issues that many hearing aid users find bothersome. Speech in noise performance measured 0.65 points above average at 2.8/5—above the category average, but only mixed in absolute terms, indicating room for improvement in the most challenging listening situations. Speech in quiet scored a solid 3.6/5, landing 0.24 points above the category average. Music streaming measured 2.9/5, slightly above average but mixed in absolute terms. Feedback handling scored an excellent 4.6/5 in absolute terms, though this fell 0.12 points below the category average of 4.72/5, reflecting the generally strong feedback control across modern prescription devices. The device showed meaningful improvement from initial to tuned fitting, with the normalized score rising from 4.2/5 to 4.6/5 after professional adjustment. This suggests that working with a hearing care professional to optimize settings can unlock additional performance, particularly for speech understanding. The Pure Charge&Go MaX appears well-suited for users who prioritize natural own-voice quality and improved conversation clarity in moderately noisy settings.